Hot Penny Stocks

Genomics & Precision Medicine Penny Stocks

US-listed genomics and precision-medicine penny stocks priced $0.50 to $5, ranked by today's percentage change. Gene editing, gene therapy, sequencing technology, liquid biopsy, companion diagnostics, and precision-medicine platforms. Updated intraday.

Data as of 7/15/2026 12:57:52 AM · Intraday prices · 54 penny stocks in theme

#	Symbol	Company	Sector	Price	Day Chg	Volume
1	XCUR	Exicure, Inc. Common Stock	Healthcare	$2.1750	+45.45%	37K
2	JSPR	Jasper Therapeutics, Inc. Common Stock	Healthcare	$0.6980	+17.62%	3.1M
3	CBUS	Cibus, Inc. Class A Common Stock	Healthcare	$2.3630	+12.44%	1.6M
4	ACRV	Acrivon Therapeutics, Inc. Common Stock	Healthcare	$2.0750	+8.33%	962K
5	QTRX	Quanterix Corporation Common Stock	Healthcare	$4.3040	+5.28%	351K
6	AVXL	Anavex Life Sciences	Healthcare	$2.4600	+4.26%	755K
7	SERA	Sera Prognostics, Inc. Class A Common Stock	Healthcare	$1.9750	+4.17%	50K
8	PHIO	Phio Pharmaceuticals Corp. Common Stock	Healthcare	$1.0400	+3.00%	101K
9	TNYA	Tenaya Therapeutics, Inc. Common Stock	Healthcare	$0.8560	+2.90%	1.7M
10	OCGN	Ocugen, Inc. Common Stock	Healthcare	$1.4410	+2.84%	4.1M
11	ALLR	Allarity Therapeutics, Inc. Common Stock	Healthcare	$1.1950	+2.65%	95K
12	CTKB	Cytek Biosciences, Inc. Common Stock	Healthcare	$4.6250	+2.44%	852K
13	MXCT	MaxCyte, Inc. Common Stock	Healthcare	$1.4260	+2.17%	1.3M
14	OABI	OmniAb, Inc. Common Stock	Healthcare	$2.1450	+1.90%	463K
15	ENGN	enGene Therapeutics Inc. Common Stock	Healthcare	$1.8600	+1.61%	1.3M
16	IMNN	Imunon, Inc. Common Stock	Healthcare	$1.9260	+1.53%	15K
17	PACB	Pacific Biosciences of California, Inc.	Healthcare	$1.5050	+1.01%	2.3M
18	MGX	Metagenomi Therapeutics, Inc. Common Stock	Healthcare	$1.3000	+0.76%	216K
19	LNAI	Lunai Bioworks Inc. Common Stock	Healthcare	$2.8940	+0.71%	29K
20	EDIT	Editas Medicine, Inc. Common Stock	Healthcare	$3.1290	+0.32%	1.6M
21	PRQR	ProQR Therapeutics N.V. Ordinary Shares	Healthcare	$1.7050	0.00%	974K
22	INO	Inovio Pharmaceuticals, Inc.	Healthcare	$1.1950	0.00%	915K
23	SNTI	Senti Biosciences Holdings, Inc. Common Stock	Healthcare	$0.9540	0.00%	57K
24	MBIO	Mustang Bio, Inc.	Healthcare	$0.6630	0.00%	19K
25	CDIO	Cardio Diagnostics Holdings Inc. Common stock	Healthcare	$1.8180	0.00%	17K
26	BGLC	BioNexus Gene Lab Corp Common stock	Healthcare	$1.7260	0.00%	5K
27	SEER	Seer, Inc. Class A Common Stock	Healthcare	$2.1650	-0.23%	122K
28	LXEO	Lexeo Therapeutics, Inc. Common Stock	Healthcare	$4.6250	-0.54%	419K
29	QSI	Quantum-Si Incorporated Class A Common Stock	Healthcare	$0.8800	-0.67%	1.1M
30	IBIO	iBio, Inc. Common Stock	Healthcare	$1.4550	-0.69%	1.0M
31	QUCY	Quantum Cyber N.V. Ordinary Shares	Healthcare	$1.2410	-0.79%	895K
32	OPK	Opko Health Inc.	Healthcare	$1.2500	-0.81%	2.4M
33	CAMP	CAMP4 Therapeutics Corporation Common Stock	Healthcare	$4.4450	-0.89%	151K
34	NAUT	Nautilus Biotechnolgy, Inc. Common Stock	Healthcare	$1.7580	-1.12%	489K
35	PRLD	Prelude Therapeutics Incorporated	Healthcare	$4.3850	-1.13%	279K
36	BNGO	Bionano Genomics, Inc. Common Stock	Healthcare	$1.1700	-1.28%	74K
37	XGN	Exagen Inc. Common Stock	Healthcare	$4.0850	-1.33%	323K
38	PRME	Prime Medicine, Inc. Common Stock	Healthcare	$3.5300	-1.42%	3.1M
39	ACIU	AC Immune SA	Healthcare	$2.4150	-1.43%	151K
40	PASG	Passage Bio, Inc. Common Stock	Healthcare	$4.4100	-1.57%	57K
41	LGVN	Longeveron Inc. Common Stock	Healthcare	$0.6420	-1.58%	170K
42	SANA	Sana Biotechnology, Inc. Common Stock	Healthcare	$3.6110	-1.79%	1.5M
43	LAB	Standard BioTools Inc. Common Stock	Healthcare	$0.8410	-1.80%	2.3M
44	IMDX	Insight Molecular Diagnostics Inc. Common Stock	Healthcare	$4.4700	-1.96%	529K
45	GNLX	Genelux Corporation Common Stock	Healthcare	$2.9800	-2.03%	169K
46	RCKT	Rocket Pharmaceuticals, Inc. Common Stock	Healthcare	$3.6490	-2.69%	919K
47	CRBU	Caribou Biosciences, Inc. Common Stock	Healthcare	$1.7740	-2.78%	1.6M
48	CCEL	Cryo-Cell International Inc.	Healthcare	$3.4100	-2.86%	4K
49	VYGR	Voyager Therapeutics, Inc. Common Stock	Healthcare	$3.1750	-2.93%	824K
50	CABA	Cabaletta Bio, Inc. Common Stock	Healthcare	$2.6990	-3.80%	2.8M

How Genomics Penny Stocks Trade

Genomics at sub-$5 is a mix of gene-editing platforms (CRISPR, base/prime editing, ZFNs), gene therapy specialists, sequencing-tool makers, and diagnostics companies. Like oncology, the trading is catalyst-driven — clinical readouts, FDA actions, and competitive technology announcements move individual names sharply.

Editing technology approach: CRISPR-Cas9, base editing, prime editing, and ZFN platforms have different IP, safety profiles, and timelines. Don't aggregate.
Gene therapy reimbursement: approved gene therapies cost $1M-$3M per patient. Payer adoption shapes commercial trajectory.
Sequencing instrument cycles: sequencing-tool plays trade with the Illumina/Element/etc. competitive landscape.
FDA novel-modality posture: the agency's evolving framework for gene/cell therapies affects approval timelines.
IP litigation: the CRISPR patent landscape has had years of litigation. Court rulings move names that depend on specific IP positions.
Manufacturing scale: gene therapies require specialized manufacturing. Companies with internal capacity trade at premiums to outsourced models.
Rare disease focus: orphan indications get faster approvals and pricing power but smaller markets. Trade-offs to weigh.
Dilution profile: like other clinical-stage biotechs, sub-$5 genomics names raise capital frequently — see our dilution explainer.